A former editor of the British Medical Journal (BMJ) claims that medical journals are an extension of the marketing arm of pharmaceutical companies, placing editors in difficult positions as company-funded trials are becoming increasingly popular. Richard Smith, now chief executive of UnitedHealth Europe, made his comments in an outspoken essay published in the open access international health journal PloS Medicine.
